H.R. 6980 · 117th Congress
To direct the Secretary of Health and Human Services to conduct a pilot program under which the Secretary increases the conduct of unannounced inspections of foreign human drug establishments and evaluates the differences between inspections of domestic and foreign human drug establishments, including the impact of announcing inspections to persons who own or operate foreign human drug establishments in advance of an inspection.
- Stage
- In committee
- Sponsor
- Richard Hudson
- Introduced
- 2022-03-08
- Latest action
- 2022-03-09 · Referred to the Subcommittee on Health.
Summary
This bill requires the Food and Drug Administration to conduct a pilot program to increase the number of unannounced inspections of foreign drug manufacturing facilities and evaluate the differences between inspections of domestic and foreign facilities.